Ethyl oleate

CAS No. 111-62-6

Ethyl oleate ( —— )

Catalog No. M27075 CAS No. 111-62-6

Ethyl oleate is the liquid lipid component in nanostructured lipid carriers (NLCs).?NLC is a promising vehicle for oral trans-Ferulic acid (TFA) administration.?

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ethyl oleate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ethyl oleate is the liquid lipid component in nanostructured lipid carriers (NLCs).?NLC is a promising vehicle for oral trans-Ferulic acid (TFA) administration.?
  • Description
    Ethyl oleate is the liquid lipid component in nanostructured lipid carriers (NLCs).?NLC is a promising vehicle for oral trans-Ferulic acid (TFA) administration.?Ethyl Oleate is a fatty acid ester formed by the condensation of oleic acid and ethanol.?
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Bacterial; Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    111-62-6
  • Formula Weight
    310.5
  • Molecular Formula
    C20H38O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCCCC\C=C/CCCCCCCC(=O)OCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sujithra K, et al. Allyl methyl sulfide, an organosulfur compound alleviates hyperglycemia mediated hepatic oxidativestress and inflammation in streptozotocin - induced experimental rats. Biomed Pharmacother. 2018 Nov;107:292-302.
molnova catalog
related products
  • Scoparone

    Extracted from A.scoparia Waldst.e Kit seeds;Store the product in sealed, cool and dry condition.

  • 3-Galloylquercitrin

    1. 3''-Galloylquercitrin possesses the activity for PTK inhibition.

  • Cajanin

    Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.